Alessandro Gronchi, MD
Fondazione IRCCS Istituto Nazionale dei Tumori (National Cancer Institute)
Alessandro Gronchi MD received his MD degree from Milan University (high honors) in 1992, and then completed his residency training in General Surgery at the San Raffaele General Hospital – Milan. During his residency he served for 2 years at the Italian Ministry of Foreign Affairs, working full time at the Lacor University Hospital in Gulu – Uganda. He then completed his training with a fellowship in Surgical Oncology at the National Cancer Institute – Milan – Italy in 1998. He joined the faculty in the Department of Surgery at National Cancer Institute, as attending surgeon in the Sarcoma Service, in 1999. He visited the Memorial Sloan Kettering Cancer Center in New York in 2002. He has been chair of the Sarcoma Service at the National Cancer Institute – Milan – Italy since 2001
Dr. Gronchi has a life-time professional dedication to patient care and research in soft tissue sarcomas (STS), desmoid-type fibromatosis (DF) and gastrointestinal stromal tumors (GIST).
His clinical practice focuses exclusively on these disease entities. He runs the Sarcoma data base of the National Cancer Institute, which gathers clinical and biological information on over 8500 patients affected by STS, DF and GIST, treated over the past 3 decades in Milan. He is involved in all institutional research activities on sarcoma, which include neoadjuvant therapies in extremity and retroperitoneal sarcomas, new targets for specific STS subtypes, different telomere maintenance mechanisms in STS subtypes, genomic characterization of DF and mechanisms of resistance to therapy in GIST. He is the Principal Investigator of several Italian and International trials on STS, DF and GIST.
He serves as chair of the soft tissue sarcoma committee of the Italian Sarcoma Group (ISG), chair of the EORTC Soft Tissue and Bone Sarcoma Group, past president of the Connective Tissue Oncology Society (CTOS) 2017, President Elect of the Italian Society of Surgical Oncology (SICO); he is a member of the European Society for Medical Oncology (ESMO), the European Society of Surgical Oncology (ESSO), the American Society of Clinical Oncology (ASCO) and the Society of Surgical Oncology (SSO) and is honorary member of the Polish Society of Surgical Oncology (PSSO). He is one of the initiators of a trans-atlantic collaborative effort on retroperitoneal sarcoma (Trans-Atlantic RetroPeritoneal Sarcoma Working Group, TARPSWG), which involves over 50 institutions worldwide. Dr. Gronchi has authored more than 270 scientific publications, serves as Associate Editor of the Sarcoma Journal, Clinical Sarcoma Research, Tumori Journal, Journal of Surgical Oncology and was Sarcoma Section Editor of the Annals of Surgical Oncology 2009-2014.